Global Bacillary Dysentery Drug Market Insights, Forecast to 2029

The global Bacillary Dysentery Drug market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Bacillary Dysentery Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The China market for Bacillary Dysentery Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The Europe market for Bacillary Dysentery Drug is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global key manufacturers of Bacillary Dysentery Drug include Akthelia Pharmaceuticals Ltd, GlaxoSmithKline Plc, Immuron Ltd, Microbiotix Inc and Protein Potential LLC, etc. In 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes:

This report presents an overview of global market for Bacillary Dysentery Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Bacillary Dysentery Drug, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Bacillary Dysentery Drug, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bacillary Dysentery Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Bacillary Dysentery Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Bacillary Dysentery Drug sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Akthelia Pharmaceuticals Ltd, GlaxoSmithKline Plc, Immuron Ltd, Microbiotix Inc and Protein Potential LLC, etc.

1.1 Bacillary Dysentery Drug Product Introduction

1.2 Market by Type

1.2.1 Global Bacillary Dysentery Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 SC-599

1.2.3 KKL-35

1.2.4 GVXNSD-133

1.2.5 SF2a-TT15

1.2.6 Others

1.3 Market by Application

1.3.1 Global Bacillary Dysentery Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2.1 Global Bacillary Dysentery Drug Sales Estimates and Forecasts 2018-2029

2.2 Global Bacillary Dysentery Drug Revenue by Region

2.2.1 Global Bacillary Dysentery Drug Revenue by Region: 2018 VS 2022 VS 2029

2.2.2 Global Bacillary Dysentery Drug Revenue by Region (2018-2023)

2.2.3 Global Bacillary Dysentery Drug Revenue by Region (2024-2029)

2.2.4 Global Bacillary Dysentery Drug Revenue Market Share by Region (2018-2029)

2.3 Global Bacillary Dysentery Drug Sales Estimates and Forecasts 2018-2029

2.4 Global Bacillary Dysentery Drug Sales by Region

2.4.1 Global Bacillary Dysentery Drug Sales by Region: 2018 VS 2022 VS 2029

2.4.2 Global Bacillary Dysentery Drug Sales by Region (2018-2023)

2.4.3 Global Bacillary Dysentery Drug Sales by Region (2024-2029)

2.4.4 Global Bacillary Dysentery Drug Sales Market Share by Region (2018-2029)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3.1 Global Bacillary Dysentery Drug Sales by Manufacturers

3.1.1 Global Bacillary Dysentery Drug Sales by Manufacturers (2018-2023)

3.1.2 Global Bacillary Dysentery Drug Sales Market Share by Manufacturers (2018-2023)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bacillary Dysentery Drug in 2022

3.2 Global Bacillary Dysentery Drug Revenue by Manufacturers

3.2.1 Global Bacillary Dysentery Drug Revenue by Manufacturers (2018-2023)

3.2.2 Global Bacillary Dysentery Drug Revenue Market Share by Manufacturers (2018-2023)

3.2.3 Global Top 10 and Top 5 Companies by Bacillary Dysentery Drug Revenue in 2022

3.3 Global Key Players of Bacillary Dysentery Drug, Industry Ranking, 2021 VS 2022 VS 2023

3.4 Global Bacillary Dysentery Drug Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Bacillary Dysentery Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Bacillary Dysentery Drug, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Bacillary Dysentery Drug, Product Offered and Application

3.8 Global Key Manufacturers of Bacillary Dysentery Drug, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4.1 Global Bacillary Dysentery Drug Sales by Type

4.1.1 Global Bacillary Dysentery Drug Historical Sales by Type (2018-2023)

4.1.2 Global Bacillary Dysentery Drug Forecasted Sales by Type (2024-2029)

4.1.3 Global Bacillary Dysentery Drug Sales Market Share by Type (2018-2029)

4.2 Global Bacillary Dysentery Drug Revenue by Type

4.2.1 Global Bacillary Dysentery Drug Historical Revenue by Type (2018-2023)

4.2.2 Global Bacillary Dysentery Drug Forecasted Revenue by Type (2024-2029)

4.2.3 Global Bacillary Dysentery Drug Revenue Market Share by Type (2018-2029)

4.3 Global Bacillary Dysentery Drug Price by Type

4.3.1 Global Bacillary Dysentery Drug Price by Type (2018-2023)

4.3.2 Global Bacillary Dysentery Drug Price Forecast by Type (2024-2029)

5.1 Global Bacillary Dysentery Drug Sales by Application

5.1.1 Global Bacillary Dysentery Drug Historical Sales by Application (2018-2023)

5.1.2 Global Bacillary Dysentery Drug Forecasted Sales by Application (2024-2029)

5.1.3 Global Bacillary Dysentery Drug Sales Market Share by Application (2018-2029)

5.2 Global Bacillary Dysentery Drug Revenue by Application

5.2.1 Global Bacillary Dysentery Drug Historical Revenue by Application (2018-2023)

5.2.2 Global Bacillary Dysentery Drug Forecasted Revenue by Application (2024-2029)

5.2.3 Global Bacillary Dysentery Drug Revenue Market Share by Application (2018-2029)

5.3 Global Bacillary Dysentery Drug Price by Application

5.3.1 Global Bacillary Dysentery Drug Price by Application (2018-2023)

5.3.2 Global Bacillary Dysentery Drug Price Forecast by Application (2024-2029)

6.1 US & Canada Bacillary Dysentery Drug Market Size by Type

6.1.1 US & Canada Bacillary Dysentery Drug Sales by Type (2018-2029)

6.1.2 US & Canada Bacillary Dysentery Drug Revenue by Type (2018-2029)

6.2 US & Canada Bacillary Dysentery Drug Market Size by Application

6.2.1 US & Canada Bacillary Dysentery Drug Sales by Application (2018-2029)

6.2.2 US & Canada Bacillary Dysentery Drug Revenue by Application (2018-2029)

6.3 US & Canada Bacillary Dysentery Drug Market Size by Country

6.3.1 US & Canada Bacillary Dysentery Drug Revenue by Country: 2018 VS 2022 VS 2029

6.3.2 US & Canada Bacillary Dysentery Drug Sales by Country (2018-2029)

6.3.3 US & Canada Bacillary Dysentery Drug Revenue by Country (2018-2029)

6.3.4 US

6.3.5 Canada

7.1 Europe Bacillary Dysentery Drug Market Size by Type

7.1.1 Europe Bacillary Dysentery Drug Sales by Type (2018-2029)

7.1.2 Europe Bacillary Dysentery Drug Revenue by Type (2018-2029)

7.2 Europe Bacillary Dysentery Drug Market Size by Application

7.2.1 Europe Bacillary Dysentery Drug Sales by Application (2018-2029)

7.2.2 Europe Bacillary Dysentery Drug Revenue by Application (2018-2029)

7.3 Europe Bacillary Dysentery Drug Market Size by Country

7.3.1 Europe Bacillary Dysentery Drug Revenue by Country: 2018 VS 2022 VS 2029

7.3.2 Europe Bacillary Dysentery Drug Sales by Country (2018-2029)

7.3.3 Europe Bacillary Dysentery Drug Revenue by Country (2018-2029)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8.1 China Bacillary Dysentery Drug Market Size

8.1.1 China Bacillary Dysentery Drug Sales (2018-2029)

8.1.2 China Bacillary Dysentery Drug Revenue (2018-2029)

8.2 China Bacillary Dysentery Drug Market Size by Application

8.2.1 China Bacillary Dysentery Drug Sales by Application (2018-2029)

8.2.2 China Bacillary Dysentery Drug Revenue by Application (2018-2029)

9.1 Asia Bacillary Dysentery Drug Market Size by Type

9.1.1 Asia Bacillary Dysentery Drug Sales by Type (2018-2029)

9.1.2 Asia Bacillary Dysentery Drug Revenue by Type (2018-2029)

9.2 Asia Bacillary Dysentery Drug Market Size by Application

9.2.1 Asia Bacillary Dysentery Drug Sales by Application (2018-2029)

9.2.2 Asia Bacillary Dysentery Drug Revenue by Application (2018-2029)

9.3 Asia Bacillary Dysentery Drug Sales by Region

9.3.1 Asia Bacillary Dysentery Drug Revenue by Region: 2018 VS 2022 VS 2029

9.3.2 Asia Bacillary Dysentery Drug Revenue by Region (2018-2029)

9.3.3 Asia Bacillary Dysentery Drug Sales by Region (2018-2029)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10.1 Middle East, Africa and Latin America Bacillary Dysentery Drug Market Size by Type

10.1.1 Middle East, Africa and Latin America Bacillary Dysentery Drug Sales by Type (2018-2029)

10.1.2 Middle East, Africa and Latin America Bacillary Dysentery Drug Revenue by Type (2018-2029)

10.2 Middle East, Africa and Latin America Bacillary Dysentery Drug Market Size by Application

10.2.1 Middle East, Africa and Latin America Bacillary Dysentery Drug Sales by Application (2018-2029)

10.2.2 Middle East, Africa and Latin America Bacillary Dysentery Drug Revenue by Application (2018-2029)

10.3 Middle East, Africa and Latin America Bacillary Dysentery Drug Sales by Country

10.3.1 Middle East, Africa and Latin America Bacillary Dysentery Drug Revenue by Country: 2018 VS 2022 VS 2029

10.3.2 Middle East, Africa and Latin America Bacillary Dysentery Drug Revenue by Country (2018-2029)

10.3.3 Middle East, Africa and Latin America Bacillary Dysentery Drug Sales by Country (2018-2029)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11.1 Akthelia Pharmaceuticals Ltd

11.1.1 Akthelia Pharmaceuticals Ltd Company Information

11.1.2 Akthelia Pharmaceuticals Ltd Overview

11.1.3 Akthelia Pharmaceuticals Ltd Bacillary Dysentery Drug Sales, Price, Revenue and Gross Margin (2018-2023)

11.1.4 Akthelia Pharmaceuticals Ltd Bacillary Dysentery Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Akthelia Pharmaceuticals Ltd Recent Developments

11.2 GlaxoSmithKline Plc

11.2.1 GlaxoSmithKline Plc Company Information

11.2.2 GlaxoSmithKline Plc Overview

11.2.3 GlaxoSmithKline Plc Bacillary Dysentery Drug Sales, Price, Revenue and Gross Margin (2018-2023)

11.2.4 GlaxoSmithKline Plc Bacillary Dysentery Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 GlaxoSmithKline Plc Recent Developments

11.3 Immuron Ltd

11.3.1 Immuron Ltd Company Information

11.3.2 Immuron Ltd Overview

11.3.3 Immuron Ltd Bacillary Dysentery Drug Sales, Price, Revenue and Gross Margin (2018-2023)

11.3.4 Immuron Ltd Bacillary Dysentery Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Immuron Ltd Recent Developments

11.4 Microbiotix Inc

11.4.1 Microbiotix Inc Company Information

11.4.2 Microbiotix Inc Overview

11.4.3 Microbiotix Inc Bacillary Dysentery Drug Sales, Price, Revenue and Gross Margin (2018-2023)

11.4.4 Microbiotix Inc Bacillary Dysentery Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Microbiotix Inc Recent Developments

11.5 Protein Potential LLC

11.5.1 Protein Potential LLC Company Information

11.5.2 Protein Potential LLC Overview

11.5.3 Protein Potential LLC Bacillary Dysentery Drug Sales, Price, Revenue and Gross Margin (2018-2023)

11.5.4 Protein Potential LLC Bacillary Dysentery Drug Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Protein Potential LLC Recent Developments

12.1 Bacillary Dysentery Drug Industry Chain Analysis

12.2 Bacillary Dysentery Drug Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Bacillary Dysentery Drug Production Mode & Process

12.4 Bacillary Dysentery Drug Sales and Marketing

12.4.1 Bacillary Dysentery Drug Sales Channels

12.4.2 Bacillary Dysentery Drug Distributors

12.5 Bacillary Dysentery Drug Customers

13.1 Bacillary Dysentery Drug Industry Trends

13.2 Bacillary Dysentery Drug Market Drivers

13.3 Bacillary Dysentery Drug Market Challenges

13.4 Bacillary Dysentery Drug Market Restraints

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

List of Tables

    Table 1. Global Bacillary Dysentery Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

    Table 2. Major Manufacturers of SC-599

    Table 3. Major Manufacturers of KKL-35

    Table 4. Major Manufacturers of GVXNSD-133

    Table 5. Major Manufacturers of SF2a-TT15

    Table 6. Major Manufacturers of Others

    Table 7. Global Bacillary Dysentery Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

    Table 8. Global Bacillary Dysentery Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 9. Global Bacillary Dysentery Drug Revenue by Region (2018-2023) & (US$ Million)

    Table 10. Global Bacillary Dysentery Drug Revenue by Region (2024-2029) & (US$ Million)

    Table 11. Global Bacillary Dysentery Drug Revenue Market Share by Region (2018-2023)

    Table 12. Global Bacillary Dysentery Drug Revenue Market Share by Region (2024-2029)

    Table 13. Global Bacillary Dysentery Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 14. Global Bacillary Dysentery Drug Sales by Region (2018-2023) & (K Pcs)

    Table 15. Global Bacillary Dysentery Drug Sales by Region (2024-2029) & (K Pcs)

    Table 16. Global Bacillary Dysentery Drug Sales Market Share by Region (2018-2023)

    Table 17. Global Bacillary Dysentery Drug Sales Market Share by Region (2024-2029)

    Table 18. Global Bacillary Dysentery Drug Sales by Manufacturers (2018-2023) & (K Pcs)

    Table 19. Global Bacillary Dysentery Drug Sales Share by Manufacturers (2018-2023)

    Table 20. Global Bacillary Dysentery Drug Revenue by Manufacturers (2018-2023) & (US$ Million)

    Table 21. Global Bacillary Dysentery Drug Revenue Share by Manufacturers (2018-2023)

    Table 22. Global Key Players of Bacillary Dysentery Drug, Industry Ranking, 2021 VS 2022 VS 2023

    Table 23. Bacillary Dysentery Drug Price by Manufacturers 2018-2023 (USD/Pcs)

    Table 24. Global Bacillary Dysentery Drug Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 25. Global Bacillary Dysentery Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bacillary Dysentery Drug as of 2022)

    Table 26. Global Key Manufacturers of Bacillary Dysentery Drug, Manufacturing Base Distribution and Headquarters

    Table 27. Global Key Manufacturers of Bacillary Dysentery Drug, Product Offered and Application

    Table 28. Global Key Manufacturers of Bacillary Dysentery Drug, Date of Enter into This Industry

    Table 29. Mergers & Acquisitions, Expansion Plans

    Table 30. Global Bacillary Dysentery Drug Sales by Type (2018-2023) & (K Pcs)

    Table 31. Global Bacillary Dysentery Drug Sales by Type (2024-2029) & (K Pcs)

    Table 32. Global Bacillary Dysentery Drug Sales Share by Type (2018-2023)

    Table 33. Global Bacillary Dysentery Drug Sales Share by Type (2024-2029)

    Table 34. Global Bacillary Dysentery Drug Revenue by Type (2018-2023) & (US$ Million)

    Table 35. Global Bacillary Dysentery Drug Revenue by Type (2024-2029) & (US$ Million)

    Table 36. Global Bacillary Dysentery Drug Revenue Share by Type (2018-2023)

    Table 37. Global Bacillary Dysentery Drug Revenue Share by Type (2024-2029)

    Table 38. Bacillary Dysentery Drug Price by Type (2018-2023) & (USD/Pcs)

    Table 39. Global Bacillary Dysentery Drug Price Forecast by Type (2024-2029) & (USD/Pcs)

    Table 40. Global Bacillary Dysentery Drug Sales by Application (2018-2023) & (K Pcs)

    Table 41. Global Bacillary Dysentery Drug Sales by Application (2024-2029) & (K Pcs)

    Table 42. Global Bacillary Dysentery Drug Sales Share by Application (2018-2023)

    Table 43. Global Bacillary Dysentery Drug Sales Share by Application (2024-2029)

    Table 44. Global Bacillary Dysentery Drug Revenue by Application (2018-2023) & (US$ Million)

    Table 45. Global Bacillary Dysentery Drug Revenue by Application (2024-2029) & (US$ Million)

    Table 46. Global Bacillary Dysentery Drug Revenue Share by Application (2018-2023)

    Table 47. Global Bacillary Dysentery Drug Revenue Share by Application (2024-2029)

    Table 48. Bacillary Dysentery Drug Price by Application (2018-2023) & (USD/Pcs)

    Table 49. Global Bacillary Dysentery Drug Price Forecast by Application (2024-2029) & (USD/Pcs)

    Table 50. US & Canada Bacillary Dysentery Drug Sales by Type (2018-2023) & (K Pcs)

    Table 51. US & Canada Bacillary Dysentery Drug Sales by Type (2024-2029) & (K Pcs)

    Table 52. US & Canada Bacillary Dysentery Drug Revenue by Type (2018-2023) & (US$ Million)

    Table 53. US & Canada Bacillary Dysentery Drug Revenue by Type (2024-2029) & (US$ Million)

    Table 54. US & Canada Bacillary Dysentery Drug Sales by Application (2018-2023) & (K Pcs)

    Table 55. US & Canada Bacillary Dysentery Drug Sales by Application (2024-2029) & (K Pcs)

    Table 56. US & Canada Bacillary Dysentery Drug Revenue by Application (2018-2023) & (US$ Million)

    Table 57. US & Canada Bacillary Dysentery Drug Revenue by Application (2024-2029) & (US$ Million)

    Table 58. US & Canada Bacillary Dysentery Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 59. US & Canada Bacillary Dysentery Drug Revenue by Country (2018-2023) & (US$ Million)

    Table 60. US & Canada Bacillary Dysentery Drug Revenue by Country (2024-2029) & (US$ Million)

    Table 61. US & Canada Bacillary Dysentery Drug Sales by Country (2018-2023) & (K Pcs)

    Table 62. US & Canada Bacillary Dysentery Drug Sales by Country (2024-2029) & (K Pcs)

    Table 63. Europe Bacillary Dysentery Drug Sales by Type (2018-2023) & (K Pcs)

    Table 64. Europe Bacillary Dysentery Drug Sales by Type (2024-2029) & (K Pcs)

    Table 65. Europe Bacillary Dysentery Drug Revenue by Type (2018-2023) & (US$ Million)

    Table 66. Europe Bacillary Dysentery Drug Revenue by Type (2024-2029) & (US$ Million)

    Table 67. Europe Bacillary Dysentery Drug Sales by Application (2018-2023) & (K Pcs)

    Table 68. Europe Bacillary Dysentery Drug Sales by Application (2024-2029) & (K Pcs)

    Table 69. Europe Bacillary Dysentery Drug Revenue by Application (2018-2023) & (US$ Million)

    Table 70. Europe Bacillary Dysentery Drug Revenue by Application (2024-2029) & (US$ Million)

    Table 71. Europe Bacillary Dysentery Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 72. Europe Bacillary Dysentery Drug Revenue by Country (2018-2023) & (US$ Million)

    Table 73. Europe Bacillary Dysentery Drug Revenue by Country (2024-2029) & (US$ Million)

    Table 74. Europe Bacillary Dysentery Drug Sales by Country (2018-2023) & (K Pcs)

    Table 75. Europe Bacillary Dysentery Drug Sales by Country (2024-2029) & (K Pcs)

    Table 76. China Bacillary Dysentery Drug Sales by Type (2018-2023) & (K Pcs)

    Table 77. China Bacillary Dysentery Drug Sales by Type (2024-2029) & (K Pcs)

    Table 78. China Bacillary Dysentery Drug Revenue by Type (2018-2023) & (US$ Million)

    Table 79. China Bacillary Dysentery Drug Revenue by Type (2024-2029) & (US$ Million)

    Table 80. China Bacillary Dysentery Drug Sales by Application (2018-2023) & (K Pcs)

    Table 81. China Bacillary Dysentery Drug Sales by Application (2024-2029) & (K Pcs)

    Table 82. China Bacillary Dysentery Drug Revenue by Application (2018-2023) & (US$ Million)

    Table 83. China Bacillary Dysentery Drug Revenue by Application (2024-2029) & (US$ Million)

    Table 84. Asia Bacillary Dysentery Drug Sales by Type (2018-2023) & (K Pcs)

    Table 85. Asia Bacillary Dysentery Drug Sales by Type (2024-2029) & (K Pcs)

    Table 86. Asia Bacillary Dysentery Drug Revenue by Type (2018-2023) & (US$ Million)

    Table 87. Asia Bacillary Dysentery Drug Revenue by Type (2024-2029) & (US$ Million)

    Table 88. Asia Bacillary Dysentery Drug Sales by Application (2018-2023) & (K Pcs)

    Table 89. Asia Bacillary Dysentery Drug Sales by Application (2024-2029) & (K Pcs)

    Table 90. Asia Bacillary Dysentery Drug Revenue by Application (2018-2023) & (US$ Million)

    Table 91. Asia Bacillary Dysentery Drug Revenue by Application (2024-2029) & (US$ Million)

    Table 92. Asia Bacillary Dysentery Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 93. Asia Bacillary Dysentery Drug Revenue by Region (2018-2023) & (US$ Million)

    Table 94. Asia Bacillary Dysentery Drug Revenue by Region (2024-2029) & (US$ Million)

    Table 95. Asia Bacillary Dysentery Drug Sales by Region (2018-2023) & (K Pcs)

    Table 96. Asia Bacillary Dysentery Drug Sales by Region (2024-2029) & (K Pcs)

    Table 97. Middle East, Africa and Latin America Bacillary Dysentery Drug Sales by Type (2018-2023) & (K Pcs)

    Table 98. Middle East, Africa and Latin America Bacillary Dysentery Drug Sales by Type (2024-2029) & (K Pcs)

    Table 99. Middle East, Africa and Latin America Bacillary Dysentery Drug Revenue by Type (2018-2023) & (US$ Million)

    Table 100. Middle East, Africa and Latin America Bacillary Dysentery Drug Revenue by Type (2024-2029) & (US$ Million)

    Table 101. Middle East, Africa and Latin America Bacillary Dysentery Drug Sales by Application (2018-2023) & (K Pcs)

    Table 102. Middle East, Africa and Latin America Bacillary Dysentery Drug Sales by Application (2024-2029) & (K Pcs)

    Table 103. Middle East, Africa and Latin America Bacillary Dysentery Drug Revenue by Application (2018-2023) & (US$ Million)

    Table 104. Middle East, Africa and Latin America Bacillary Dysentery Drug Revenue by Application (2024-2029) & (US$ Million)

    Table 105. Middle East, Africa and Latin America Bacillary Dysentery Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 106. Middle East, Africa and Latin America Bacillary Dysentery Drug Revenue by Country (2018-2023) & (US$ Million)

    Table 107. Middle East, Africa and Latin America Bacillary Dysentery Drug Revenue by Country (2024-2029) & (US$ Million)

    Table 108. Middle East, Africa and Latin America Bacillary Dysentery Drug Sales by Country (2018-2023) & (K Pcs)

    Table 109. Middle East, Africa and Latin America Bacillary Dysentery Drug Sales by Country (2024-2029) & (K Pcs)

    Table 110. Akthelia Pharmaceuticals Ltd Company Information

    Table 111. Akthelia Pharmaceuticals Ltd Description and Major Businesses

    Table 112. Akthelia Pharmaceuticals Ltd Bacillary Dysentery Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 113. Akthelia Pharmaceuticals Ltd Bacillary Dysentery Drug Product Model Numbers, Pictures, Descriptions and Specifications

    Table 114. Akthelia Pharmaceuticals Ltd Recent Developments

    Table 115. GlaxoSmithKline Plc Company Information

    Table 116. GlaxoSmithKline Plc Description and Major Businesses

    Table 117. GlaxoSmithKline Plc Bacillary Dysentery Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 118. GlaxoSmithKline Plc Bacillary Dysentery Drug Product Model Numbers, Pictures, Descriptions and Specifications

    Table 119. GlaxoSmithKline Plc Recent Developments

    Table 120. Immuron Ltd Company Information

    Table 121. Immuron Ltd Description and Major Businesses

    Table 122. Immuron Ltd Bacillary Dysentery Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 123. Immuron Ltd Bacillary Dysentery Drug Product Model Numbers, Pictures, Descriptions and Specifications

    Table 124. Immuron Ltd Recent Developments

    Table 125. Microbiotix Inc Company Information

    Table 126. Microbiotix Inc Description and Major Businesses

    Table 127. Microbiotix Inc Bacillary Dysentery Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 128. Microbiotix Inc Bacillary Dysentery Drug Product Model Numbers, Pictures, Descriptions and Specifications

    Table 129. Microbiotix Inc Recent Developments

    Table 130. Protein Potential LLC Company Information

    Table 131. Protein Potential LLC Description and Major Businesses

    Table 132. Protein Potential LLC Bacillary Dysentery Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)

    Table 133. Protein Potential LLC Bacillary Dysentery Drug Product Model Numbers, Pictures, Descriptions and Specifications

    Table 134. Protein Potential LLC Recent Developments

    Table 135. Key Raw Materials Lists

    Table 136. Raw Materials Key Suppliers Lists

    Table 137. Bacillary Dysentery Drug Distributors List

    Table 138. Bacillary Dysentery Drug Customers List

    Table 139. Bacillary Dysentery Drug Market Trends

    Table 140. Bacillary Dysentery Drug Market Drivers

    Table 141. Bacillary Dysentery Drug Market Challenges

    Table 142. Bacillary Dysentery Drug Market Restraints

    Table 143. Research Programs/Design for This Report

    Table 144. Key Data Information from Secondary Sources

    Table 145. Key Data Information from Primary Sources

List of Figures

    Figure 1. Bacillary Dysentery Drug Product Picture

    Figure 2. Global Bacillary Dysentery Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

    Figure 3. Global Bacillary Dysentery Drug Market Share by Type in 2022 & 2029

    Figure 4. SC-599 Product Picture

    Figure 5. KKL-35 Product Picture

    Figure 6. GVXNSD-133 Product Picture

    Figure 7. SF2a-TT15 Product Picture

    Figure 8. Others Product Picture

    Figure 9. Global Bacillary Dysentery Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

    Figure 10. Global Bacillary Dysentery Drug Market Share by Application in 2022 & 2029

    Figure 11. Hospital

    Figure 12. Clinic

    Figure 13. Others

    Figure 14. Bacillary Dysentery Drug Report Years Considered

    Figure 15. Global Bacillary Dysentery Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Bacillary Dysentery Drug Revenue 2018-2029 (US$ Million)

    Figure 17. Global Bacillary Dysentery Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029

    Figure 18. Global Bacillary Dysentery Drug Revenue Market Share by Region (2018-2029)

    Figure 19. Global Bacillary Dysentery Drug Sales 2018-2029 ((K Pcs)

    Figure 20. Global Bacillary Dysentery Drug Sales Market Share by Region (2018-2029)

    Figure 21. US & Canada Bacillary Dysentery Drug Sales YoY (2018-2029) & (K Pcs)

    Figure 22. US & Canada Bacillary Dysentery Drug Revenue YoY (2018-2029) & (US$ Million)

    Figure 23. Europe Bacillary Dysentery Drug Sales YoY (2018-2029) & (K Pcs)

    Figure 24. Europe Bacillary Dysentery Drug Revenue YoY (2018-2029) & (US$ Million)

    Figure 25. China Bacillary Dysentery Drug Sales YoY (2018-2029) & (K Pcs)

    Figure 26. China Bacillary Dysentery Drug Revenue YoY (2018-2029) & (US$ Million)

    Figure 27. Asia (excluding China) Bacillary Dysentery Drug Sales YoY (2018-2029) & (K Pcs)

    Figure 28. Asia (excluding China) Bacillary Dysentery Drug Revenue YoY (2018-2029) & (US$ Million)

    Figure 29. Middle East, Africa and Latin America Bacillary Dysentery Drug Sales YoY (2018-2029) & (K Pcs)

    Figure 30. Middle East, Africa and Latin America Bacillary Dysentery Drug Revenue YoY (2018-2029) & (US$ Million)

    Figure 31. The Bacillary Dysentery Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022

    Figure 32. The Top 5 and 10 Largest Manufacturers of Bacillary Dysentery Drug in the World: Market Share by Bacillary Dysentery Drug Revenue in 2022

    Figure 33. Global Bacillary Dysentery Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

    Figure 34. Global Bacillary Dysentery Drug Sales Market Share by Type (2018-2029)

    Figure 35. Global Bacillary Dysentery Drug Revenue Market Share by Type (2018-2029)

    Figure 36. Global Bacillary Dysentery Drug Sales Market Share by Application (2018-2029)

    Figure 37. Global Bacillary Dysentery Drug Revenue Market Share by Application (2018-2029)

    Figure 38. US & Canada Bacillary Dysentery Drug Sales Market Share by Type (2018-2029)

    Figure 39. US & Canada Bacillary Dysentery Drug Revenue Market Share by Type (2018-2029)

    Figure 40. US & Canada Bacillary Dysentery Drug Sales Market Share by Application (2018-2029)

    Figure 41. US & Canada Bacillary Dysentery Drug Revenue Market Share by Application (2018-2029)

    Figure 42. US & Canada Bacillary Dysentery Drug Revenue Share by Country (2018-2029)

    Figure 43. US & Canada Bacillary Dysentery Drug Sales Share by Country (2018-2029)

    Figure 44. U.S. Bacillary Dysentery Drug Revenue (2018-2029) & (US$ Million)

    Figure 45. Canada Bacillary Dysentery Drug Revenue (2018-2029) & (US$ Million)

    Figure 46. Europe Bacillary Dysentery Drug Sales Market Share by Type (2018-2029)

    Figure 47. Europe Bacillary Dysentery Drug Revenue Market Share by Type (2018-2029)

    Figure 48. Europe Bacillary Dysentery Drug Sales Market Share by Application (2018-2029)

    Figure 49. Europe Bacillary Dysentery Drug Revenue Market Share by Application (2018-2029)

    Figure 50. Europe Bacillary Dysentery Drug Revenue Share by Country (2018-2029)

    Figure 51. Europe Bacillary Dysentery Drug Sales Share by Country (2018-2029)

    Figure 52. Germany Bacillary Dysentery Drug Revenue (2018-2029) & (US$ Million)

    Figure 53. France Bacillary Dysentery Drug Revenue (2018-2029) & (US$ Million)

    Figure 54. U.K. Bacillary Dysentery Drug Revenue (2018-2029) & (US$ Million)

    Figure 55. Italy Bacillary Dysentery Drug Revenue (2018-2029) & (US$ Million)

    Figure 56. Russia Bacillary Dysentery Drug Revenue (2018-2029) & (US$ Million)

    Figure 57. China Bacillary Dysentery Drug Sales Market Share by Type (2018-2029)

    Figure 58. China Bacillary Dysentery Drug Revenue Market Share by Type (2018-2029)

    Figure 59. China Bacillary Dysentery Drug Sales Market Share by Application (2018-2029)

    Figure 60. China Bacillary Dysentery Drug Revenue Market Share by Application (2018-2029)

    Figure 61. Asia Bacillary Dysentery Drug Sales Market Share by Type (2018-2029)

    Figure 62. Asia Bacillary Dysentery Drug Revenue Market Share by Type (2018-2029)

    Figure 63. Asia Bacillary Dysentery Drug Sales Market Share by Application (2018-2029)

    Figure 64. Asia Bacillary Dysentery Drug Revenue Market Share by Application (2018-2029)

    Figure 65. Asia Bacillary Dysentery Drug Revenue Share by Region (2018-2029)

    Figure 66. Asia Bacillary Dysentery Drug Sales Share by Region (2018-2029)

    Figure 67. Japan Bacillary Dysentery Drug Revenue (2018-2029) & (US$ Million)

    Figure 68. South Korea Bacillary Dysentery Drug Revenue (2018-2029) & (US$ Million)

    Figure 69. China Taiwan Bacillary Dysentery Drug Revenue (2018-2029) & (US$ Million)

    Figure 70. Southeast Asia Bacillary Dysentery Drug Revenue (2018-2029) & (US$ Million)

    Figure 71. India Bacillary Dysentery Drug Revenue (2018-2029) & (US$ Million)

    Figure 72. Middle East, Africa and Latin America Bacillary Dysentery Drug Sales Market Share by Type (2018-2029)

    Figure 73. Middle East, Africa and Latin America Bacillary Dysentery Drug Revenue Market Share by Type (2018-2029)

    Figure 74. Middle East, Africa and Latin America Bacillary Dysentery Drug Sales Market Share by Application (2018-2029)

    Figure 75. Middle East, Africa and Latin America Bacillary Dysentery Drug Revenue Market Share by Application (2018-2029)

    Figure 76. Middle East, Africa and Latin America Bacillary Dysentery Drug Revenue Share by Country (2018-2029)

    Figure 77. Middle East, Africa and Latin America Bacillary Dysentery Drug Sales Share by Country (2018-2029)

    Figure 78. Brazil Bacillary Dysentery Drug Revenue (2018-2029) & (US$ Million)

    Figure 79. Mexico Bacillary Dysentery Drug Revenue (2018-2029) & (US$ Million)

    Figure 80. Turkey Bacillary Dysentery Drug Revenue (2018-2029) & (US$ Million)

    Figure 81. Israel Bacillary Dysentery Drug Revenue (2018-2029) & (US$ Million)

    Figure 82. GCC Countries Bacillary Dysentery Drug Revenue (2018-2029) & (US$ Million)

    Figure 83. Bacillary Dysentery Drug Value Chain

    Figure 84. Bacillary Dysentery Drug Production Process

    Figure 85. Channels of Distribution

    Figure 86. Distributors Profiles

    Figure 87. Bottom-up and Top-down Approaches for This Report

    Figure 88. Data Triangulation

    Figure 89. Key Executives Interviewed